Company Overview

Vystar Corporation (OTC: VYST) is a U.S.-based company that has operated in specialty materials, healthcare-related products, and air purification technologies through a combination of internal development and acquisitions. Public filings and company disclosures indicate that the company has historically focused on products derived from its proprietary latex technology platform, marketed under the Vytex brand, as well as air purification systems sold through the RxAir business. The company has also previously maintained interests in retail furniture operations and other consumer-oriented assets, although the scale and operational status of some business lines have varied over time based on restructuring activities and financial conditions disclosed in public filings.

The company’s historical revenue drivers have included sales tied to air purification products, licensing or commercialization efforts involving latex technologies, and acquired operating businesses. Vystar has positioned itself around environmentally focused and health-oriented products, particularly through latex products intended to reduce allergens and through indoor air quality technologies. The company was founded in the early 2000s and evolved through acquisitions, licensing arrangements, and diversification into adjacent product categories. Certain historical operational details and segment performance metrics are difficult to independently confirm from recent public disclosures, and some information remains limited due to the company’s OTC market status and evolving reporting profile.

Business Operations

Vystar’s operations have historically included the RxAir air purification business and the company’s proprietary Vytex natural rubber latex technology platform. The RxAir segment has focused on portable air purification systems intended for residential, healthcare, educational, and commercial environments, with marketing emphasis on UV-C and HEPA-based purification technologies. The Vytex platform was developed to produce reduced-protein natural rubber latex products intended to lower exposure to latex allergens in products such as gloves, mattresses, and medical or consumer applications.

The company has primarily operated in the United States, though its technology and commercialization efforts have included relationships with manufacturers and distributors outside the U.S. Public disclosures also indicate prior ownership or involvement with Rotmans Furniture, which represented a diversification into furniture retail operations. Vystar’s business model has combined direct product sales, licensing opportunities, and acquired operating assets. Data regarding the current contribution of each operating unit is inconclusive based on available public sources, and recent public disclosures suggest the company has undergone operational restructuring and strategic reassessment.

Strategic Position & Investments

Vystar’s strategic direction has historically centered on commercializing proprietary technologies and expanding through acquisitions or strategic operating subsidiaries. The company has invested in air purification products through RxAir and sought broader adoption of its latex technologies through manufacturing and licensing arrangements. Public filings and investor materials have emphasized indoor air quality, healthcare-related demand, and environmentally conscious materials as long-term thematic opportunities.

The company’s acquisition history has included Rotmans Furniture and other operating interests intended to diversify revenue streams. Vystar has also promoted the potential application of its latex technology across healthcare, bedding, and industrial sectors. However, the scale of these initiatives and their commercial traction have varied over time, and some publicly announced strategic initiatives have not been accompanied by extensive independently verifiable operating results. Data regarding the current status of certain subsidiaries, investments, or commercialization agreements is inconclusive based on available public sources.

Geographic Footprint

Vystar Corporation is headquartered in the United States, and its primary operational focus has historically been concentrated within the U.S. market. The company’s air purification and specialty materials businesses have targeted domestic commercial, healthcare, educational, and consumer customers. Its acquisition activity and retail operations have also largely centered on U.S.-based assets.

The company’s broader commercial ambitions have included international licensing and manufacturing relationships associated with its latex technology platform. Public disclosures have referenced opportunities involving overseas production and global product applications, though independently verifiable details regarding sustained international operational scale remain limited. The company does not appear to maintain the same global operational footprint as large multinational industrial or healthcare firms.

Leadership & Governance

Vystar Corporation was founded by William Doyle, who has historically played a central role in the development and commercialization strategy surrounding the company’s latex technology platform. Public filings indicate that leadership has emphasized technology commercialization, acquisition-led diversification, and product positioning tied to health and environmental themes.

Key executives and leadership figures identified in public disclosures include:

• William Doyle – Founder and former Chief Executive Officer
• Steven Rotman – Executive associated with Rotmans Furniture operations
• Hector Gomez – Executive leadership role referenced in company disclosures related to operations and corporate management

Recent executive roles and governance structures may have changed over time, and some leadership information is difficult to verify consistently across all current public sources. Data inconclusive based on available public sources.